| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $32.1M | -39.9% |
| Cost of Revenue | $10.6M | -11.4% |
| Gross Profit | $21.5M | -48.2% |
| R&D Expense | $17.4M | -37.3% |
| SG&A Expense | $28.4M | -38.3% |
| Operating Income | -$50.2M | +36.5% |
| Pre-tax Income | -$6.5M | +91.9% |
| Income Tax | $718K | +172.0% |
| Net Income | -$7.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $15.4M | -59.6% |
| Accounts Receivable | $7.1M | -60.8% |
| Inventory | $3.4M | -44.9% |
| Current Assets | $27.2M | -58.1% |
| Total Assets | $32.8M | -54.2% |
| Current Liabilities | $18.9M | -71.2% |
| Long-term Debt | $35.7M | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$42.3M | +33.9% |
| Capital Expenditures | $611K | -62.0% |
| Investing Cash Flow | -$611K | +62.0% |
| Financing Cash Flow | $20.2M | -78.9% |
| Free Cash Flow | -$42.9M | +34.6% |
| +91.1% |
| EPS (Basic) | -$3.20 | -38.5% |
| EPS (Diluted) | -$3.20 | -38.5% |
| Total Liabilities |
| $110.8M |
| -22.1% |
| Stockholders' Equity | -$78.0M | -10.6% |